Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: An ultrastructural study

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Saggu, Sarabjit K ^a   Chotaliya, Hiren P ^a   Blumbergs, Peter C ^b   Casson, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANSON INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ORGANELLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEMYELINATION; ENDOPLASMIC RETICULUM; EXCITOTOXICITY; MALE; MITOCHONDRION SWELLING; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE DISEASE; PERIKARYON; POLYSOME; RAT; RETINA GANGLION CELL; RETINA INJURY; ANIMAL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DEMYELINATING DISEASE; DRUG EFFECT; MITOCHONDRION; NERVE DEGENERATION; NERVE FIBER; OPTIC NERVE; PATHOLOGY; RETINA; SPRAGUE DAWLEY RAT; TISSUE FIXATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AMINO ACID RECEPTOR STIMULATING AGENT; N METHYLASPARTIC ACID;

ANIMALS; AXONS; DEMYELINATING DISEASES; ENDOPLASMIC RETICULUM; EXCITATORY AMINO ACID AGONISTS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; N-METHYLASPARTATE; NERVE DEGENERATION; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; TISSUE FIXATION; WALLERIAN DEGENERATION;

EID: 77955493297     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-97     Document Type: Article

References (68)

1. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 1999, 81(3):163-221. 10.1016/S0163-7258(98)00042-4, 10334661.
2. Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003, 3(2):65-94. 10.1385/NMM:3:2:65, 12728191.
3. Tannenberg RK, Scott HL, Westphalen RI, Dodd PR. The identification and characterization of excitotoxic nerve-endings in Alzheimer disease. Curr Alzheimer Res 2004, 1(1):11-25. 10.2174/1567205043480591, 15975081.
4. Tsai VW, Scott HL, Lewis RJ, Dodd PR. The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Neurotox Res 2005, 7(12):125-141. 10.1007/BF03033782, 15639804.
5. Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004, 45(5):583-595. 10.1016/j.neuint.2004.03.007, 15234100.
6. Hynd MR, Scott HL, Dodd PR. Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's disease. J Neurochem 2004, 90(4):913-919. 10.1111/j.1471-4159.2004.02548.x, 15287897.
7. Johnston MV. Excitotoxicity in perinatal brain injury. Brain Pathol 2005, 15(3):234-240. 10.1111/j.1750-3639.2005.tb00526.x, 16196390.
8. Lipton SA. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2005, 2(2):155-165. 10.2174/1567205053585846, 15974913.
9. Ludolph AC, Meyer T, Riepe MW. The role of excitotoxicity in ALS--what is the evidence?. J Neurol 2000, 247(Suppl 1):I7-16. 10.1007/s004150050552, 10795882.
10. Van Damme P, Dewil M, Robberecht W, Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener Dis 2005, 2(34):147-159. 10.1159/000089620, 16909020.
11. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004, 23(1):91-147. 10.1016/j.preteyeres.2003.12.001, 14766318.
12. Casson RJ. Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin Experiment Ophthalmol 2006, 34(1):54-63. 10.1111/j.1442-9071.2006.01146.x, 16451260.
13. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, et al. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease. Science 2005, 307(5713):1282-1288. 10.1126/science.1105681, 15731448.
14. Fischer D, Grothe C, Schmidt S, Schröder R. On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy. Journal of Neurology 2004, 251(10):1204-1207. 10.1007/s00415-004-0507-z, 15503098.
15. Li S, Stys PK. Na+-K+-ATPase inhibition and depolarization induce glutamate release via reverse Na+-dependent transport in spinal cord white matter. Neuroscience 2001, 107(4):675-683. 10.1016/S0306-4522(01)00385-2, 11720790.
16. Libby RT, Yan L, Savinova OV, Barter J, Smith RS, Nickells RW, John SWM, Valle D. Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene Dosage. PLoS Genetics 2005, 1(1):17-26. 10.1371/journal.pgen.0010004, 1183523, 16103918.
17. Jun Z, Jeffrey SD. Distinct perisynaptic and synaptic localization of NMDA and AMPA receptors on ganglion cells in rat retina. The Journal of Comparative Neurology 2006, 498(6):810-820. 10.1002/cne.21089, 2577313, 16927255.
18. Mohamed O, Elaine C, Ajoy B, Andrew C, Gerald WZ, Shameed H, Renata R, Xinghua Y, Bruce DT, Peter KS. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Annals of Neurology 2009, 65(2):151-159. 10.1002/ana.21533, 2902553, 19224535.
19. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438(7071):1167-1171. 10.1038/nature04301, 16372012.
20. Tekkok SB, Ye Z, Ransom BR. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007, 27(9):1540-1552. 10.1038/sj.jcbfm.9600455, 17299453.
21. Saggu SK, Chotaliya HP, Cai Z, Blumbergs P, Casson RJ. The spatiotemporal pattern of somal and axonal pathology after perikaryal excitotoxic injury to retinal ganglion cells: A histological and morphometric study. Experimental Neurology 2008, 211(1):52-58. 10.1016/j.expneurol.2007.12.022, 18313053.
22. Morizane C, Adachi K, Furutani I, Fujita Y, Akaike A, Kashii S, Honda Y. N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur J Pharmacol 1997, 328(1):45-49. 10.1016/S0014-2999(97)83026-9, 9203567.
23. Honjo M, Tanihara H, Kido N, Inatani M, Okazaki K, Honda Y. Expression of Ciliary Neurotrophic Factor Activated by Retinal Muller Cells in Eyes with NMDA- and Kainic Acid-Induced Neuronal Death. Invest Ophthalmol Vis Sci 2000, 41(2):552-560.
24. Borsello T, Mottier V, Castagné V, Clarke P. Ultrastructure of retinal ganglion cell death after axotomy in chick embryos. The Journal of Comparative Neurology 2002, 453(4):361-371. 10.1002/cne.10411, 12389208.
25. Fix AS, Horn JW, Hall RL, Johnson JA, Tizzano JP. Progressive retinal toxicity in neonatal rats treated with D,L-2-amino-3-phosphonopropionate (D,L-AP3). Vet Pathol 1995, 32(5):521-531. 10.1177/030098589503200510, 8578643.
26. Forrester J, Peters A. Nerve fibres in optic nerve of rat. Nature 1967, 214(5085):245-247. 10.1038/214245a0, 4166494.
27. Waxman SG, Black JA, Stys PK, Ransom BR. Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res 1992, 574(12):105-119. 10.1016/0006-8993(92)90806-K, 1638387.
28. Waxman SG, Black JA, Ransom BR, Stys PK. Anoxic injury of rat optic nerve: ultrastructural evidence for coupling between Na+ influx and Ca(2+)-mediated injury in myelinated CNS axons. Brain Res 1994, 644(2):197-204. 10.1016/0006-8993(94)91680-2, 8050031.
29. Peters A, Vaughn JE. Microtubules and filaments in the axons and astrocytes of early postnatal rat optic nerves. J Cell Biol 1967, 32(1):113-119. 10.1083/jcb.32.1.113, 2107085, 10976204.
30. Carbonell A, Boya J, Calvo J, Marin J. Ultrastructural study of the neuroglial and macrophagic reaction in Wallerian degeneration of the adult rat optic nerve. Histol Histopathol 1991, 6(4):443-451.
31. Liu K, Shen C. Ultrastructural sequence of myelin breakdown during Wallerian degeneration in the rat optic nerve. Cell Tissue Res 1985, 242(2):245-256. 10.1007/BF00214537, 4053169.
32. Khan A. Wallerian degeneration in the optic nerve of the rabbit. Cells Tissues Organs 2004, 177(2):104-109. 10.1159/000079185, 15297784.
33. Beirowski B, Babetto E, Coleman MP, Martin KR. The Wld gene delays axonal but not somatic degeneration in a rat glaucoma model. European Journal of Neuroscience 2008, 28(6):1166-1179. 10.1111/j.1460-9568.2008.06426.x, 18783366.
34. Gilley J, Coleman MP. Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons. PLoS Biol 8(1):e1000300. 10.1371/journal.pbio.1000300, 2811159, 20126265.
35. Du Y, Bales KR, Dodel RC, Hamilton-Byrd E, Horn JW, Czilli DL, Simmons LK, Ni B, Paul SM. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc Natl Acad Sci USA 1997, 94(21):11657-11662. 10.1073/pnas.94.21.11657, 23571, 9326666.
36. Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Letters 1996, 394(3):321-324. 10.1016/0014-5793(96)00959-3, 8830666.
37. Esrefoglu M, Gepdiremen A, Kurus M. Ultrastructural clues for glutamate-induced necrosis in parietal and cerebellar neurons. Fundamental & Clinical Pharmacology 2003, 17(3):341-347.
38. Portera-Cailliau C, Price DL, Martin LJ. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol 1997, 378(1):70-87.
39. Portera-Cailliau C, Price DL, Martin LJ. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 1997, 378(1):88-104. 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G, 9120056.
40. Mironova EV, Evstratova AA, Antonov SM. A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture. Journal of Neuroscience Methods 2007, 163(1):1-8. 10.1016/j.jneumeth.2007.02.010, 17395268.
41. Calderó J, Tarabal O, Casanovas A, Ciutat D, Casas C, Lladó J, Esquerda JE. Excitotoxic motoneuron disease in chick embryo evolves with autophagic neurodegeneration and deregulation of neuromuscular innervation. Journal of Neuroscience Research 2007, 9999(9999). NA.
42. Ientile R, Macaione V, Teletta M, Pedale S, Torre V, Macaione S. Apoptosis and necrosis occurring in excitotoxic cell death in isolated chick embryo retina. J Neurochem 2001, 79(1):71-78. 10.1046/j.1471-4159.2001.00532.x, 11595759.
43. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Neurodegeneration in Excitotoxicity, Global Cerebral Ischemia, and Target Deprivation: A Perspective on the Contributions of Apoptosis and Necrosis. Brain Research Bulletin 1998, 46(4):281-309. 10.1016/S0361-9230(98)00024-0, 9671259.
44. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15(4):961-973. 10.1016/0896-6273(95)90186-8, 7576644.
45. Auer RN, Coulter KC. The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. Acta Neuropathol (Berl) 1994, 87(1):1-7.
46. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GG, Storts RW, Farber N, Wozniak DF, Olney JW. Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl--aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex. Experimental Neurology 1993, 123(2):204-215. 10.1006/exnr.1993.1153, 8405286.
47. Searle J, Kerr JF, Bishop CJ. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 1982, 17(Pt 2):229-259.
48. Williams AR, Piris J, Spandidos DA, Wyllie AH. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer 1985, 52(5):687-693. 1977224, 3904801.
49. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306. 10.1016/S0074-7696(08)62312-8, 7014501.
50. Walker NI, Harmon BV, Gobe GC, Kerr JF. Patterns of cell death. Methods Achiev Exp Pathol 1988, 13:18-54.
51. Wyllie AH, Duvall E. Cell injury and death. Oxford textbook of pathology 1992, 141-150. New York: Oxford University Press, Oxford, McGee JOD, Isaacson PG, Wright NA.
52. Schuettauf F, Rejdak R, Walski M, Frontczak-Baniewicz M, Voelker M, Blatsios G, Shinoda K, Zagorski Z, Zrenner E, Grieb P. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (Berl) 2004, 107(4):352-358. Epub 2004 Jan 2024.
53. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995, 36(5):774-786.
54. Wyllie AH, Beattie GJ, Hargreaves AD. Chromatin changes in apoptosis. Histochem J 1981, 13(4):681-692. 10.1007/BF01002719, 6975767.
55. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Current Opinion in Cell Biology 2004, 16(6):663-669. 10.1016/j.ceb.2004.09.011, 15530778.
56. Curtis DR, Headley PM, Lodge D. Depolarization of feline primary afferent fibres by acidic amino acids. J Physiol 1984, 351(1):461-472. 1193128, 6747872.
57. Curtis DR, Lodge D, Bornstein JC, Peet MJ, Leah JD. The dual effects of GABA and related amino acids on the electrical threshold of ventral horn group Ia afferent terminations in the cat. Exp Brain Res 1982, 48(3):387-400. 10.1007/BF00238615, 6295795.
58. Evans RH. Evidence supporting the indirect depolarization of primary afferent terminals in the frog by excitatory amino acids. J Physiol 1980, 298(1):25-35. 1279099, 6965722.
59. Ishise J, Rosenbluth J. Nodal and paranodal structural changes in frog optic nerve during early Wallerian degeneration. J Neurocytol 1986, 15(5):657-670. 10.1007/BF01611864, 3490546.
60. Maxwell WL, Irvine A, Adams JH, Gennarelli TA, Tipperman R, Sturatis M. Focal axonal injury: the early axonal response to stretch. J Neurocytol 1991, 20(3):157-164. 10.1007/BF01186989, 1709964.
61. Maxwell WL, McCreath BJ, Graham DI, Gennarelli TA. Cytochemical evidence for redistribution of membrane pump calcium-ATPase and ecto-Ca-ATPase activity, and calcium influx in myelinated nerve fibres of the optic nerve after stretch injury. J Neurocytol 1995, 24(12):925-942. 10.1007/BF01215643, 8719820.
62. Buki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol 1999, 58(4):365-375. 10.1097/00005072-199904000-00007, 10218632.
63. Buki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol 1999, 58(4):365-375. 10.1097/00005072-199904000-00007, 10218632.
64. Okonkwo DO, Pettus EH, Moroi J, Povlishock JT. Alteration of the neurofilament sidearm and its relation to neurofilament compaction occurring with traumatic axonal injury. Brain Research 1998, 784(12):1-6. 10.1016/S0006-8993(97)01075-5, 9518527.
65. Povlishock JT, Pettus EH. Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir Suppl 1996, 66:81-86.
66. Narciso MS, Hokoc JN, Martinez AM. Watery and dark axons in Wallerian degeneration of the opossum's optic nerve: different patterns of cytoskeletal breakdown?. An Acad Bras Cienc 2001, 73(2):231-243.
67. Butt AM, Kirvell S. Glial cells in transected optic nerves of immature rats. II. An immunohistochemical study. J Neurocytol 1996, 25(6):381-392. 10.1007/BF02284809, 8835786.
68. Liu KM, Shen CL. Ultrastructural sequence of myelin breakdown during Wallerian degeneration in the rat optic nerve. Cell Tissue Res 1985, 242(2):245-256. 10.1007/BF00214537, 4053169.